NicePostNuke.PancreaticTrialNotFailure.SuccessWillBeShownAtASCO! WhyWouldAnyoneThink that PPHM would be silly enough to make a presentation at ASCO and just to say, "Look how bavi failed its pancreatic trial!"
On the contrary, wait until ASCO and find out. In the meantime, don't be surprised if word of Bavi's success leaks out before ASCO and interest in PPHM stock begins to climb pushing PPS up.
BUT, what if the sub-group analysis shows complete responses
I think you have the right idea, but wouldn't limit it to one indication. I anticipate we'll see a significant number in remission for the 2nd line NSCLC trial and breast cancer trial at ASCO, too.